Neuronal heparan sulfates promote amyloid pathology by modulating brain amyloid-β clearance and aggregation in Alzheimer's disease.
about
Amelioration of amyloid-β-induced deficits by DcR3 in an Alzheimer's disease model.Metabolic relationship between diabetes and Alzheimer's Disease affected by Cyclo(His-Pro) plus zinc treatment.Structure Based Substrate Specificity Analysis of Heparan Sulfate 6-O-Sulfotransferases.Cellular internalization of alpha-synuclein aggregates by cell surface heparan sulfate depends on aggregate conformation and cell typeApolipoprotein E and Alzheimer's disease: the influence of apolipoprotein E on amyloid-β and other amyloidogenic proteins.Apolipoprotein E, Receptors, and Modulation of Alzheimer's Disease.Amyloid plaques beyond Aβ: a survey of the diverse modulators of amyloid aggregation.Loss of clusterin shifts amyloid deposition to the cerebrovasculature via disruption of perivascular drainage pathways.High-density lipoproteins suppress Aβ-induced PBMC adhesion to human endothelial cells in bioengineered vessels and in monoculture.Astrocytic LRP1 Mediates Brain Aβ Clearance and Impacts Amyloid Deposition.Heparan sulfate: Resilience factor and therapeutic target for cocaine abuse.Practical considerations for choosing a mouse model of Alzheimer's disease.ApoE4 Accelerates Early Seeding of Amyloid Pathology.Apolipoprotein E4 Impairs Neuronal Insulin Signaling by Trapping Insulin Receptor in the Endosomes.Modelling Neurodegenerative Microenvironment Using Cortical Organoids Derived from Human Stem Cells.Heparan Sulfate Proteoglycans as Relays of Neuroinflammation.Perlecan Domain V Inhibits Amyloid-β Induced Activation of the α2β1 Integrin-Mediated Neurotoxic Signaling Cascade.Heparan Sulfates Promote Amyloid Pathology in Alzheimer Disease.APOE ε2 is associated with increased tau pathology in primary tauopathy
P2860
Q30846817-E4DF69CB-FEF5-450C-AA2D-D1AC9F142D05Q37569276-647611C8-D3E3-41C9-B0D5-CD4CA390D7A4Q38406589-E533FE20-6162-4626-B50B-AA49EB54D7D9Q38694463-4DE7867D-807C-4526-8CF4-E6446757B3E2Q39155261-C110DD99-B60F-403B-B204-5A7D62E2FF31Q39257249-7AF7E6E0-CD52-4242-AB13-F620AA277556Q39385143-49234355-83DE-4D28-9362-A0D1EA49D5F7Q41476892-7A70ED5E-350F-4447-AA00-CF8FB1EDC57EQ41497977-BC5B2366-7202-43F4-97F9-A1E1F2793ACFQ42291622-76FD34E0-61A4-4C97-9873-BD7CF24A2D53Q42638635-78E28783-0BC7-45FD-A6B9-FBA56D47349AQ47135235-89677277-6538-4747-BA71-D32474556B15Q47319238-4ADD678F-1929-427F-9960-FA0F9D67A278Q47731042-A1AA740A-7B73-4F0C-8D12-F26095347E55Q47844178-D4B11CD7-87FB-4F98-B7E1-72D753E22CE6Q47888806-307E72A0-12AC-4053-A42F-5E2DBC62D7CDQ48468895-109D5860-C494-44D3-9C78-52573C0EEDCCQ51634595-EA06BF38-5560-4A32-B71F-C5DDDA300E81Q57804769-71F1D1FF-F1B6-4808-A84B-3A0D24B58747
P2860
Neuronal heparan sulfates promote amyloid pathology by modulating brain amyloid-β clearance and aggregation in Alzheimer's disease.
description
2016 nî lūn-bûn
@nan
2016 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի մարտին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Neuronal heparan sulfates prom ...... gation in Alzheimer's disease.
@ast
Neuronal heparan sulfates prom ...... gation in Alzheimer's disease.
@en
type
label
Neuronal heparan sulfates prom ...... gation in Alzheimer's disease.
@ast
Neuronal heparan sulfates prom ...... gation in Alzheimer's disease.
@en
prefLabel
Neuronal heparan sulfates prom ...... gation in Alzheimer's disease.
@ast
Neuronal heparan sulfates prom ...... gation in Alzheimer's disease.
@en
P2093
P2860
P1476
Neuronal heparan sulfates prom ...... gation in Alzheimer's disease.
@en
P2093
Chia-Chen Liu
John R Cirrito
Takahisa Kanekiyo
Yu Yamaguchi
P2860
P304
P356
10.1126/SCITRANSLMED.AAD3650
P407
P577
2016-03-01T00:00:00Z